By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Benzodiazepines > Temazepam > Temazepam Side Effects
Benzodiazepines

Temazepam Side Effects

Summary

More frequently reported side effects include: dizziness, insomnia, lethargy, and irritability. Continue reading for a comprehensive list of adverse effects.

Applies to temazepam: oral capsules.

Warning

    Concomitant Use with Opiates
  • Concomitant use of benzodiazepines and opiates may result in profound sedation, respiratory depression, coma, and death.700 701 703 705 706 707

  • Reserve concomitant use for patients in whom alternative treatment options are inadequate; use lowest effective dosages and shortest possible duration of concomitant therapy and monitor closely for respiratory depression and sedation.700 703 (See Specific Drugs under Interactions.)

    Potential for Abuse, Addiction, and Other Serious Risks
  • A boxed warning has been included in the prescribing information for all benzodiazepines describing risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions.900

  • Abuse and misuse can result in overdose or death, especially when benzodiazepines are combined with other medicines, such as opioid pain relievers, alcohol, or illicit drugs.900

  • Assess a patient’s risk of abuse, misuse, and addiction.900 Standardized screening tools are available ([Web]).900

  • To reduce risk of acute withdrawal reactions, use a gradual dose taper when reducing dosage or discontinuing benzodiazepines.900 Take precautions when benzodiazepines are used in combination with opioid medications.900

Side effects include:

Drowsiness, fatigue, lethargy, dizziness, hangover, anxiety, diarrhea, euphoria, weakness, confusion, vertigo.

For Healthcare Professionals

Applies to temazepam: oral capsule.

General

The most commonly reported side effects included drowsiness, headache, and fatigue.[Ref]

Nervous system

Lightheadedness, slurred speech, and unsteadiness usually occur at the start of treatment and disappear with repeated doses.[Ref]

Common (1% to 10%): Dizziness, drowsiness, hangover, headache, lethargy, sedation, vertigo

Uncommon (0.1% to 1%): Ataxia, equilibrium loss, faintness, muzziness, sciatica, taste loss, tremor

Rare (0.01% to 0.1%): Dysarthria

Frequency not reported: Amnesia, anterograde amnesia, coma, convulsions, daytime drowsiness, epileptic seizures, extrapyramidal symptoms, extremity tingling, horizontal nystagmus, hypersensitivity to light/noise/physical contact, impaired concentration, lightheadedness, numbness, oversedation, perceptual disturbances, reduced alertness, seizures, slurred speech, unsteadiness[Ref]

Psychiatric

Common (1% to 10%): Anxiety, confusion, depression, euphoria, nervousness, nightmares

Uncommon (0.1% to 1%): Decreased orgasm, disorientation, increased dreaming, irritability, libido changes, unmasking of depression, vivid dreams

Rare (0.01% to 0.1%): Restless sleep

Frequency not reported: Abuse, aggressiveness/aggression, agitation, broken sleep (with vivid dreams), confusional states, delusion, depersonalization, dependence, derealization, disinhibition, excitement, extreme anxiety, hallucinations, hostility, inappropriate behavior, insomnia, mood changes, numbed emotions, other adverse behavioral effects, overstimulation, physical dependence, psychological dependence, psychoses, psychotic manifestations, rage, rebound insomnia, restlessness, sexual arousal, sleep disturbance, stimulation, suicidal attempt, suicidal ideation, tension, withdrawal effects/symptoms[Ref]

Dependence and numbed emotions usually occur at the start of treatment and disappear with repeated doses.[Ref]

Gastrointestinal

Common (1% to 10%): Abdominal discomfort, diarrhea, dry mouth, nausea

Uncommon (0.1% to 1%): Gastrointestinal upset, vomiting

Rare (0.01% to 0.1%): Salivation changes

Frequency not reported: Abdominal cramps, constipation, gastrointestinal disturbances[Ref]

Other

Common (1% to 10%): Fatigue, weakness

Uncommon (0.1% to 1%): Asthenia

Frequency not reported: Falls, hyperacusis, hypothermia, paradoxical reactions, rebound phenomenon, tinnitus[Ref]

Ocular

Common (1% to 10%): Blurred vision

Uncommon (0.1% to 1%): Burning eyes

Rare (0.01% to 0.1%): Visual disturbances

Frequency not reported: Diplopia/double vision, photophobia[Ref]

Double vision usually occurs at the start of treatment and disappears with repeated doses.[Ref]

Dermatologic

Uncommon (0.1% to 1%): Allergic skin reactions, hyperhidrosis, macular rash, pruritus

Rare (0.01% to 0.1%): Skin reactions

Frequency not reported: Alopecia, sweating[Ref]

Hematologic

Uncommon (0.1% to 1%): Increased neutrophils, leukocytosis

Rare (0.01% to 0.1%): Blood disorders, blood dyscrasias

Frequency not reported: Agranulocytosis, pancytopenia, thrombocytopenia[Ref]

Hepatic

Uncommon (0.1% to 1%): Increased AST, increased bilirubin

Rare (0.01% to 0.1%): Abnormal liver function, jaundice

Frequency not reported: Increased liver enzymes[Ref]

Genitourinary

Uncommon (0.1% to 1%): Impotence, proteinuria

Rare (0.01% to 0.1%): Incontinence, urinary retention[Ref]

Cardiovascular

Uncommon (0.1% to 1%): Palpitations, tachycardia

Rare (0.01% to 0.1%): Hypotension

Frequency not reported: Lowering in blood pressure, mild systolic hypertension, orthostatic hypotension[Ref]

Musculoskeletal

Uncommon (0.1% to 1%): Backache, leg cramps

Rare (0.01% to 0.1%): Impaired muscular function

Frequency not reported: Muscle pain, muscle weakness[Ref]

Muscle weakness usually occurs at the start of treatment and disappears with repeated doses.[Ref]

Respiratory

Respiratory depression usually occurs at the start of treatment and disappears with repeated doses.[Ref]

Uncommon (0.1% to 1%): Breathlessness, dyspnea

Frequency not reported: Apnea, respiratory depression, worsening of obstructive pulmonary disease, worsening of sleep apnea[Ref]

Metabolic

Uncommon (0.1% to 1%): Anorexia, increased serum alkaline phosphatase

Frequency not reported: Hyponatremia, loss of appetite[Ref]

Renal

Uncommon (0.1% to 1%): Increased blood urea nitrogen[Ref]

Hypersensitivity

Rare (0.01% to 0.1%): Fatal anaphylaxis

Frequency not reported: Hypersensitivity reactions, severe anaphylactic reaction, severe anaphylactoid reaction[Ref]

Endocrine

Frequency not reported: Syndrome of inappropriate antidiuretic hormone secretion (SIADH)[Ref]

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by